NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

15 hedge funds and large institutions have $2.25M invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 0 closing their positions.

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SL
1
Sentinus LLC
Illinois
$1.45M
2
AA
2
Ancora Advisors
Ohio
$413K
3
MCM
3
MAI Capital Management
Ohio
$15.7K
4
AMG
4
Advisors Management Group
Wisconsin
$8K
5
WJWM
5
Williams Jones Wealth Management
New York
$34.5K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
SL
1
Sentinus LLC
Illinois
$1.45M 1,794,790 +600,375 +50%
AA
2
Ancora Advisors
Ohio
$413K 526,000 +29,000 +6%
MSAM
3
Moloney Securities Asset Management
Missouri
$224K 285,460 +300 +0.1%
OCG
4
Opus Capital Group
Ohio
$47K 60,150 +5,000 +9%
WJWM
5
Williams Jones Wealth Management
New York
$34.5K 44,000 +5,000 +13%
LDB
6
Lee, Danner & Bass
Tennessee
$16K 20,000 – –
MCM
7
MAI Capital Management
Ohio
$15.7K 20,000 +20,000 New
GWI
8
Grace & White Inc
New York
$11.5K 14,705 – –
AA
9
AlphaMark Advisors
Kentucky
$11K 14,007 – –
GG
10
Gofen & Glossberg
Illinois
$10K 12,740 – –
AMG
11
Advisors Management Group
Wisconsin
$8K 10,270 +10,270 New
ECM
12
Estabrook Capital Management
New York
$5.49K 7,000 – –
BCWM
13
Bartlett & Co Wealth Management
Ohio
$3.37K 4,292 – –
BC
14
Bartlett & Co
Ohio
$3K 4,292 – –
HFS
15
Hantz Financial Services
Michigan
$0 250 – –